Passage BIO, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Passage BIO, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q3 2024.
  • Passage BIO, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$19.3M, a 28.7% increase year-over-year.
  • Passage BIO, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$68.8M, a 38.8% increase year-over-year.
  • Passage BIO, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$102M, a 25% increase from 2022.
  • Passage BIO, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$136M, a 26.6% increase from 2021.
  • Passage BIO, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$185M, a 65.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$68.8M -$19.3M +$7.77M +28.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$76.6M -$16M +$7.87M +33% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$84.4M -$16.7M +$17.6M +51.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$102M -$16.8M +$10.3M +38.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-04
Q3 2023 -$112M -$27.1M -$409K -1.53% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$112M -$23.9M +$15.7M +39.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$128M -$34.3M +$8.47M +19.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$136M -$27.1M +$24.1M +47.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-04
Q3 2022 -$160M -$26.7M +$20.2M +43.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$180M -$39.5M +$8.89M +18.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$189M -$42.8M -$3.93M -10.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$185M -$51.2M -$12.2M -31.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 -$173M -$46.9M -$18.4M -64.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$155M -$48.4M -$21.3M -78.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$134M -$38.9M -$21.3M -121% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$112M -$38.9M -$25.8M -196% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-03
Q3 2020 -$86.4M -$28.5M -$17.1M -151% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$69.3M -$27.2M -$13.7M -102% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$55.6M -$17.6M -$9.92M -129% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$45.6M -$13.2M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-03
Q3 2019 -$11.4M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$13.4M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$7.67M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.